- Home
- ZDGE vs LITS Comparison
ZDGE vs LITS Comparison
Compare ZDGE & LITS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZDGE | LITS |
|---|---|---|
| Founded | 2008 | 2000 |
| Country | United States | United States |
| Employees | 55 | 4 |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 44.1M | 41.5M |
| IPO Year | 2016 | N/A |
Fundamental Metrics
Financial Performance| Metric | ZDGE | LITS |
|---|---|---|
| Price | $3.21 | $1.15 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 66.2K | ★ 219.6K |
| Earning Date | 06-11-2026 | 05-19-2026 |
| Dividend Yield | ★ 1.96% | N/A |
| EPS Growth | ★ 73.85 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $29,398,000.00 | N/A |
| Revenue This Year | $3.27 | N/A |
| Revenue Next Year | $5.78 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.12 | $0.95 |
| 52 Week High | $4.70 | $3.03 |
Technical Indicators
Market Signals| Indicator | ZDGE | LITS |
|---|---|---|
| Relative Strength Index (RSI) | 51.03 | 48.02 |
| Support Level | $2.90 | $1.12 |
| Resistance Level | $3.19 | $1.16 |
| Average True Range (ATR) | 0.19 | 0.05 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 36.00 | 29.29 |
Price Performance
Historical ComparisonAbout ZDGE Zedge Inc. Class B
Zedge Inc builds digital marketplaces and competitive games centered on content that people use for self-expression. Its products include the Zedge App, a freemium digital content marketplace offering mobile wallpapers, video wallpapers, ringtones, and notification sounds, along with pAInt, a generative AI wallpaper and ringtone maker, GuruShots, a skill-based photo challenge game, and Emojipedia, a trusted source for emoji information. The Zedge App is available on Google Play and the App Store. The company operates two segments: Zedge Marketplace and GuruShots, with the majority of revenue generated from the Zedge Marketplace.
About LITS Lite Strategy Inc.
Lite Strategy Inc is focused on the clinical development of novel therapies for cancer. The company's portfolio of drug candidates includes voruciclib, an oral cyclin-dependent kinase 9 (CDK9) inhibitor and zandelisib, an oral, once-daily, selective PI3K inhibitor. It is a clinical-stage pharmaceutical company committed to the development of novel and differentiated cancer therapies intended to improve outcomes for patients.